Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1962 May 19;1(5289):1359–1366. doi: 10.1136/bmj.1.5289.1359

Jaundice*

Sheila Sherlock
PMCID: PMC1958466  PMID: 13911711

Full text

PDF
1359

Images in this article

1365Fig. 10
on p.1365

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHRENS E. H., Jr, PAYNE M. A., KUNKEL H. G., EISENMENGER W. J., BLONDHEIM S. H. Primary biliary cirrhosis. Medicine (Baltimore) 1950 Dec;29(4):299–364. doi: 10.1097/00005792-195012000-00002. [DOI] [PubMed] [Google Scholar]
  2. ARIAS I. M., LONDON I. M. Bilirubin glucuronide formation in vitro; demonstration of a defect in Gilbert's disease. Science. 1957 Sep 20;126(3273):563–564. doi: 10.1126/science.126.3273.563. [DOI] [PubMed] [Google Scholar]
  3. BAIKIE A. G. The chromatographic separation of the serum bile pigments in jaundice. Scott Med J. 1957 Sep;2(9):359–362. doi: 10.1177/003693305700200903. [DOI] [PubMed] [Google Scholar]
  4. BALLARD H., BERNSTEIN M., FARRAR J. T. Fatty liver presenting as obstructive jaundice. Am J Med. 1961 Feb;30:196–201. doi: 10.1016/0002-9343(61)90091-2. [DOI] [PubMed] [Google Scholar]
  5. BARNIVILLE H. T., MISK R. Urinary glucuronic acid excretion in liver disease and the effect of a salicylamide load. Br Med J. 1959 Feb 7;1(5118):337–340. doi: 10.1136/bmj.1.5118.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BEKER S., READ A. E. Familial DubinJohnson syndrome. Gastroenterology. 1958 Oct;35(4):387–389. [PubMed] [Google Scholar]
  7. BILLING B. H., COLE P. G., LATHE G. H. The excretion of bilirubin as a diglucuronide giving the direct van den Bergh reaction. Biochem J. 1957 Apr;65(4):774–784. doi: 10.1042/bj0650774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. BILLING B. H. The three serum bile pigments in obstructive jaundice and hepatitis. J Clin Pathol. 1955 May;8(2):130–131. doi: 10.1136/jcp.8.2.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BROWN A. K., ZUELZER W. W. Studies on the neonatal development of the glucuronide conjugating system. J Clin Invest. 1958 Mar;37(3):332–340. doi: 10.1172/JCI103613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BYNUM W. T. Mavero-hepatic icterus, black liver jaundice. Gastroenterology. 1957 Jul;33(1):97–103. [PubMed] [Google Scholar]
  11. CAESAR J., SHALDON S., CHIANDUSSI L., GUEVARA L., SHERLOCK S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961 Aug;21:43–57. [PubMed] [Google Scholar]
  12. CARBONE J. V., GRODSKY G. M. Constitutional nonhemolytic hyperbilirubinemia in the rat: defect of bilirubin conjugation. Proc Soc Exp Biol Med. 1957 Mar;94(3):461–463. doi: 10.3181/00379727-94-22979. [DOI] [PubMed] [Google Scholar]
  13. CHALMERS T. C., GILL R. J., JERNIGAN T. P., SVEC F. A., JORDAN R. S., WALDSTEIN S. S., KNOWLTON M. Evaluation of a four-day ACTH test in the differential diagnosis of jaundice. Gastroenterology. 1956 Jun;30(6):894–899. [PubMed] [Google Scholar]
  14. COLE P. G., LATHE G. H., BILLING B. H. Separation of the bile pigments of serum, bile and urine. Biochem J. 1954 Jul;57(3):514–518. doi: 10.1042/bj0570514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. CRIGLER J. F., Jr, NAJJAR V. A. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 1952 Aug;10(2):169–180. [PubMed] [Google Scholar]
  16. CROSBY W. H., AKEROYD J. H. The limit of hemoglobin synthesis in hereditary hemolytic anemia; its relation to the excretion of bile pigment. Am J Med. 1952 Sep;13(3):273–283. doi: 10.1016/0002-9343(52)90282-9. [DOI] [PubMed] [Google Scholar]
  17. DEUTSCH L., DICKES R., SCHENKER V. Serial liver-function and blood studies in patients receiving chlorpromazine. N Engl J Med. 1957 Jan 3;256(1):1–7. doi: 10.1056/NEJM195701032560101. [DOI] [PubMed] [Google Scholar]
  18. DUBIN I. N. Chronic idiopathic jaundice; a review of fifty cases. Am J Med. 1958 Feb;24(2):268–292. doi: 10.1016/0002-9343(58)90315-2. [DOI] [PubMed] [Google Scholar]
  19. DUBIN I. N., JOHNSON F. B. Chronic idiopathic jaundice with unidentified pigment in liver cells; a new clinicopathologic entity with a report of 12 cases. Medicine (Baltimore) 1954 Sep;33(3):155–197. doi: 10.1097/00005792-195409000-00001. [DOI] [PubMed] [Google Scholar]
  20. DUNNING M. F. Jaundice associated with norethandrolone (Nilevar) administration. J Am Med Assoc. 1958 Jul 5;167(10):1242–1243. doi: 10.1001/jama.1958.72990270011009d. [DOI] [PubMed] [Google Scholar]
  21. EANET M. P., BRICK I. B. Constitutional hyperbilirubinemia: its differential diagnosis and the effect of steroid therapy. N Engl J Med. 1955 Dec 15;253(24):1062–1065. doi: 10.1056/NEJM195512152532403. [DOI] [PubMed] [Google Scholar]
  22. ELKES J., ELKES C. Effect of chlorpromazine on the behavior of chronically overactive psychotic patients. Br Med J. 1954 Sep 4;2(4887):560–565. doi: 10.1136/bmj.2.4887.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. FOSS G. L., SIMPSON S. L. Oral methyltestosterone and jaundice. Br Med J. 1959 Jan 31;1(5117):259–263. doi: 10.1136/bmj.1.5117.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. GRAY C. H. The bile pigments. Br Med Bull. 1957 May;13(2):94–98. doi: 10.1093/oxfordjournals.bmb.a069602. [DOI] [PubMed] [Google Scholar]
  25. HEANEY R. P., WHEDON G. D. Impairment of hepatic bromsulphalein clearance by two 17-substituted testosterones. J Lab Clin Med. 1958 Aug;52(2):169–175. [PubMed] [Google Scholar]
  26. HOLLISTER L. E. Allergy to chlorpromazine manifested by jaundice. Am J Med. 1957 Dec;23(6):870–879. doi: 10.1016/0002-9343(57)90296-6. [DOI] [PubMed] [Google Scholar]
  27. ISSELBACHER K. J., McCARTHY E. A. Studies on bilirubin sulfate and other nonglucuronide conjugates of bilirubin. J Clin Invest. 1959 Apr;38(4):645–651. doi: 10.1172/JCI103842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. JOHN G. G., KNUDTSON K. P. Chronic idiopathic jaundice; two cases occurring in siblings, with histochemical studies. Am J Med. 1956 Jul;21(1):138–142. doi: 10.1016/0002-9343(56)90030-4. [DOI] [PubMed] [Google Scholar]
  29. KEMP J. A. Jaundice occurring during administration of promazine. Gastroenterology. 1957 May;32(5):937–938. [PubMed] [Google Scholar]
  30. KING A., MITCHELL P. H., SYKES P. Effects of pacatal on symptoms in chronic psychotic female in-patients. Br Med J. 1957 Jan 26;1(5012):204–207. doi: 10.1136/bmj.1.5012.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. KLATSKIN G., BUNGARDS L. Bilirubinprotein linkages in serum and their relationship to the van den Bergh reaction. J Clin Invest. 1956 May;35(5):537–551. doi: 10.1172/JCI103307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. KLATSKIN G. Bile pigment metabolism. Annu Rev Med. 1961;12:211–250. doi: 10.1146/annurev.me.12.020161.001235. [DOI] [PubMed] [Google Scholar]
  33. KOHN N., MYERSON R. M. Cholestatic hepatitis associated with trifluoperazine. N Engl J Med. 1961 Mar 16;264:549–550. doi: 10.1056/NEJM196103162641107. [DOI] [PubMed] [Google Scholar]
  34. KORY R. C., BRADLEY M. H., WATSON R. N., CALLAHAN R., PETERS B. J. A six-month evaluation of an anabolic drug, norethandrolone, in underweight persons. II. Bromsulphalein (BSP) retention and liver function. Am J Med. 1959 Feb;26(2):243–248. doi: 10.1016/0002-9343(59)90313-4. [DOI] [PubMed] [Google Scholar]
  35. LESTER R., OSTROW J. D., SCHMID R. Enterohepatic circulation of bilirubin. Nature. 1961 Oct 28;192:372–372. doi: 10.1038/192372a0. [DOI] [PubMed] [Google Scholar]
  36. LICHTENSTEIN M. R., CANNEMEYER W. Severe para-aminosalicylic acid hypersensitivity simulating mononucleosis or hepatitis. J Am Med Assoc. 1953 Jun 13;152(7):606–607. doi: 10.1001/jama.1953.63690070002010a. [DOI] [PubMed] [Google Scholar]
  37. LLOYD-THOMAS H. G. L., SHERLOCK S. Testosterone therapy for the pruritus of obstructive jaundice. Br Med J. 1952 Dec 13;2(4797):1289–1291. doi: 10.1136/bmj.2.4797.1289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. LONDON I. M., WEST R., SHEMIN D., RITTENBERG D. On the origin of bile pigment in normal man. J Biol Chem. 1950 May;184(1):351–358. [PubMed] [Google Scholar]
  39. MANDEMA E., de FRAITURE W., NIEWEG H. O., ARENDS A. Familial chronic idiopathic jaundice (Dubin-Sprinz disease), with a note on bromsulphalein metabolism in this disease. Am J Med. 1960 Jan;28:42–50. doi: 10.1016/0002-9343(60)90221-7. [DOI] [PubMed] [Google Scholar]
  40. MARQUARDT G. H., FISHER C. I., LEVY P., DOWBEN R. M. Effect of anabolic steroids on liver function tests and creatine excretion. JAMA. 1961 Mar 11;175:851–853. doi: 10.1001/jama.1961.03040100015005. [DOI] [PubMed] [Google Scholar]
  41. MECHANIC R. C., MEYERS L. Chlorpromazine-type cholangitis; report of a case occurring after the administration of prochlorperazine. N Engl J Med. 1958 Oct 16;259(16):778–780. doi: 10.1056/NEJM195810162591607. [DOI] [PubMed] [Google Scholar]
  42. NURICK A. W., PATEY D. H., WHITESIDE C. G. Percutaneous transhepatic cholangiography in the diagnosis of obstructive jaundice. Br J Surg. 1953 Jul;41(165):27–30. doi: 10.1002/bjs.18004116509. [DOI] [PubMed] [Google Scholar]
  43. PARONETTO F., SCHAFFNER F., POPPER H. Immunocytochemical reaction of serum of patients with hepatic diseases with hepatic structures. Proc Soc Exp Biol Med. 1961 Jan;106:216–219. doi: 10.3181/00379727-106-26291. [DOI] [PubMed] [Google Scholar]
  44. PHILLIPS G. B., DAVIDSON C. S. Acute hepatic insufficiency of the chronic alcoholic; clinical and pathological study. AMA Arch Intern Med. 1954 Oct;94(4):585–603. doi: 10.1001/archinte.1954.00250040077007. [DOI] [PubMed] [Google Scholar]
  45. POPPER H., SCHAFFNER F. Pathology of jaundice resulting from intrahepatic cholestasis. J Am Med Assoc. 1959 Mar 28;169(13):1447–1453. doi: 10.1001/jama.1959.03000300043009. [DOI] [PubMed] [Google Scholar]
  46. RADKE R. A., BAROODY W. G. Carbarsone toxicity: a review of the literature and report of 45 cases. Ann Intern Med. 1957 Sep;47(3):418–427. doi: 10.7326/0003-4819-47-3-418. [DOI] [PubMed] [Google Scholar]
  47. READ A. E., HARRISON C. V., SHERLOVK S. Chronic chlorpromazine jaundice: with particular reference to its relationship to primary biliary cirrhosis. Am J Med. 1961 Aug;31:249–258. doi: 10.1016/0002-9343(61)90113-9. [DOI] [PubMed] [Google Scholar]
  48. REICHEL J., GOLDBERG S. B., ELLENBERG M., SCHAFFNER F. Intrahepatic cholestasis following administration of chlorpropamide. Report of a case with electron microscopic observations. Am J Med. 1960 Apr;28:654–660. doi: 10.1016/0002-9343(60)90161-3. [DOI] [PubMed] [Google Scholar]
  49. SCHAFFNER F., POPPER H. Morphologic studies of cholestasis. Gastroenterology. 1959 Nov;37:565–573. [PubMed] [Google Scholar]
  50. SCHAFFNER F., POPPER H., PEREZ V. Changes in bile canaliculi produced by norethandrolone: electron microscopic study of human and rat liver. J Lab Clin Med. 1960 Oct;56:623–628. [PubMed] [Google Scholar]
  51. SCHIFF L., BILLING B. H., OIKAWA Y. Familial nonhemolytic jaundice with conjugated bilirubin in the serum; a case study. N Engl J Med. 1959 Jun 25;260(26):1315–1318. doi: 10.1056/NEJM195906252602604. [DOI] [PubMed] [Google Scholar]
  52. SCHMID R. Direct-reacting bilirubin, bilirubin glucuronide, in serum, bile and urine. Science. 1956 Jul 13;124(3211):76–77. doi: 10.1126/science.124.3211.76. [DOI] [PubMed] [Google Scholar]
  53. SCHMID R., HAMMAKER L., AXELROD J. The enzymatic formation of bilirubin glucuronide. Arch Biochem Biophys. 1957 Jul;70(1):285–288. doi: 10.1016/0003-9861(57)90103-0. [DOI] [PubMed] [Google Scholar]
  54. SCHMID R., HAMMAKER L. Glucuronide formation in patients with constitutional hepatic dysfunction (Gilbert's disease). N Engl J Med. 1959 Jun 25;260(26):1310–1314. doi: 10.1056/NEJM195906252602603. [DOI] [PubMed] [Google Scholar]
  55. SHIPP J. C. Jaundice during methimazole (tapazole) administration. Ann Intern Med. 1955 Mar;42(3):701–706. doi: 10.7326/0003-4819-42-3-701. [DOI] [PubMed] [Google Scholar]
  56. SPRINZ H., NELSON R. S. Persistent non-hemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of four cases. Ann Intern Med. 1954 Nov;41(5):952–962. doi: 10.7326/0003-4819-41-5-952. [DOI] [PubMed] [Google Scholar]
  57. SUMMERSKILL W. H., JONES F. A. Corticotrophin and steroids in the diagnosis and management of obstructive jaundice. Br Med J. 1958 Dec 20;2(5111):1499–1502. doi: 10.1136/bmj.2.5111.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. SVANBORG A., OHLSSON S. Recurrent jaundice of pregnancy; a clinical study of twenty-two cases. Am J Med. 1959 Jul;27(1):40–49. doi: 10.1016/0002-9343(59)90059-2. [DOI] [PubMed] [Google Scholar]
  59. TALAFANT E. Properties and composition of the bile pigment giving a direct diazo reaction. Nature. 1956 Aug 11;178(4528):312–312. doi: 10.1038/178312a0. [DOI] [PubMed] [Google Scholar]
  60. TISDALE W. A., KLATSKIN G., KINSELLA E. D. The significance of the direct-reacting fraction of serum bilirubin in hemolytic jaundice. Am J Med. 1959 Feb;26(2):214–227. doi: 10.1016/0002-9343(59)90310-9. [DOI] [PubMed] [Google Scholar]
  61. WAITZKIN L. Hepatic dysfunction during promazine therapy. N Engl J Med. 1957 Aug 8;257(6):276–277. doi: 10.1056/NEJM195708082570607. [DOI] [PubMed] [Google Scholar]
  62. WEINSTEIN A., ALPER B. J., DADE J. R. Cholestasis due to prochlorperazine. J Am Med Assoc. 1959 Aug 1;170(14):1663–1664. doi: 10.1001/jama.1959.63010140003011a. [DOI] [PubMed] [Google Scholar]
  63. WERNER S. C., HANGER F. M., KRITZLER R. A. Jaundice during methyl testosterone therapy. Am J Med. 1950 Mar;8(3):325–331. doi: 10.1016/0002-9343(50)90065-9. [DOI] [PubMed] [Google Scholar]
  64. WILLIAMS R., BILLING B. H. Action of steroid therapy in jaundice. Lancet. 1961 Aug 19;2(7199):392–396. doi: 10.1016/s0140-6736(61)92481-3. [DOI] [PubMed] [Google Scholar]
  65. WOLF R. L., PIZETTE M., RICHMAN A., DREILING D. A., JACOBS W., FERNANDEZ O., POPPER H. Chronic idiopathic jaundice. A study of two afflicted families. Am J Med. 1960 Jan;28:32–41. doi: 10.1016/0002-9343(60)90220-5. [DOI] [PubMed] [Google Scholar]
  66. WYNN V., LANDON J., KAWERAU E. Studies of hepatic function during methandienone therapy. Lancet. 1961 Jan 14;1(7168):69–75. doi: 10.1016/s0140-6736(61)92118-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES